Department of Neurobiology, Physiology and Behavior, University of California, Davis, California 95616, USA.
J Comp Neurol. 2012 Dec 1;520(17):4032-49. doi: 10.1002/cne.23159.
Dopamine can regulate signal generation and transmission by activating multiple receptors and signaling cascades, especially in striatum, hippocampus, and cerebral cortex. Dopamine modulates an even larger variety of cellular properties in retina, yet has been reported to do so by only D1 receptor-driven cyclic adenosine monophosphate (cAMP) increases or D2 receptor-driven cAMP decreases. Here, we test the possibility that dopamine operates differently on retinal ganglion cells, because the ganglion cell layer binds D1 and D2 receptor ligands, and displays changes in signaling components other than cAMP under illumination that should release dopamine. In adult rat retinal ganglion cells, based on patch-clamp recordings, Ca(2+) imaging, and immunohistochemistry, we find that 1) spike firing is inhibited by dopamine and SKF 83959 (an agonist that does not activate homomeric D1 receptors or alter cAMP levels in other systems); 2) D1 and D2 receptor antagonists (SCH 23390, eticlopride, raclopride) counteract these effects; 3) these antagonists also block light-induced rises in cAMP, light-induced activation of Ca(2+) /calmodulin-dependent protein kinase II, and dopamine-induced Ca(2+) influx; and 4) the Ca(2+) rise is markedly reduced by removing extracellular Ca(2+) and by an IP3 receptor antagonist (2-APB). These results provide the first evidence that dopamine activates a receptor in adult mammalian retinal neurons that is distinct from classical D1 and D2 receptors, and that dopamine can activate mechanisms in addition to cAMP and cAMP-dependent protein kinase to modulate retinal ganglion cell excitability.
多巴胺可以通过激活多种受体和信号级联来调节信号的产生和传递,特别是在纹状体、海马体和大脑皮层中。多巴胺还可以调节视网膜中更多种类的细胞特性,但据报道,它是通过 D1 受体驱动的环腺苷酸 (cAMP) 增加或 D2 受体驱动的 cAMP 减少来实现的。在这里,我们测试了多巴胺在视网膜神经节细胞中可能以不同的方式发挥作用的可能性,因为神经节细胞层结合了 D1 和 D2 受体配体,并且在光照下显示出除 cAMP 之外的信号成分的变化,这些变化应该会释放多巴胺。在成年大鼠视网膜神经节细胞中,我们通过膜片钳记录、钙成像和免疫组织化学发现:1)多巴胺和 SKF 83959(一种不会激活同源 D1 受体或改变其他系统中 cAMP 水平的激动剂)抑制峰发放;2)D1 和 D2 受体拮抗剂(SCH 23390、eticlopride、raclopride)拮抗这些作用;3)这些拮抗剂也阻断光诱导的 cAMP 升高、光诱导的 Ca2+/钙调蛋白依赖性蛋白激酶 II 的激活以及多巴胺诱导的 Ca2+内流;4)去除细胞外 Ca2+和 IP3 受体拮抗剂(2-APB)可显著降低钙上升。这些结果首次提供了证据,表明多巴胺在成年哺乳动物视网膜神经元中激活了一种不同于经典 D1 和 D2 受体的受体,并且多巴胺可以激活除 cAMP 和 cAMP 依赖性蛋白激酶之外的机制来调节视网膜神经节细胞的兴奋性。